Merck KGaA (FRA:MRK) received a €114.00 ($122.58) price objective from research analysts at BNP Paribas in a research report issued on Thursday. The brokerage presently has a a “buy” rating on the stock.

Several other analysts have also recently weighed in on MRK. Berenberg Bank set a €101.00 ($108.60) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research report on Friday, July 22nd. Deutsche Bank AG set a €110.00 ($118.28) price target on shares of Merck KGaA and gave the company a “buy” rating in a report on Thursday, July 28th. Morgan Stanley set a €103.00 ($110.75) price target on shares of Merck KGaA and gave the company a “neutral” rating in a report on Monday, August 1st. Warburg Research set a €103.10 ($110.86) price objective on Merck KGaA and gave the company a “buy” rating in a report on Thursday, August 4th. Finally, equinet AG set a €85.00 ($91.40) price objective on Merck KGaA and gave the company a “buy” rating in a report on Thursday, August 4th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and ten have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of €101.91 ($109.58).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Shares of Merck KGaA (FRA:MRK) opened at 93.36 on Thursday. The company has a market cap of €40.59 billion and a P/E ratio of 29.21. Merck KGaA has a 1-year low of €70.87 and a 1-year high of €100.00. The stock has a 50 day moving average price of €95.61 and a 200-day moving average price of €92.97.

About Merck KGaA

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.